(2S)-5-[[(5S)-6-[[(1S)-2-[[(1S)-2-[[(1S)-1-[[(1S)-1-[[(1S)-2-[[(1S)-4-amino-1-[[(1S)-2-[[(1S)-2-[[(1S,2S)-1-[[(1S)-1-[[(1S)-2-[[(1S)-1-[[(1S)-5-amino-1-[[(1S)-3-amino-1-[[2-[[2-[(2S)-2-[[(1S)-2-[[(1S)-2-[[2-[[(1S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[[(1S)-2-amino-1-(hydroxymethyl)-2-oxo-ethyl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-1-methyl-2-oxo-ethyl]amino]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]carbamoyl]pyrrolidin-1-yl]-2-oxo-ethyl]amino]-2-oxo-ethyl]carbamoyl]-3-oxo-propyl]carbamoyl]pentyl]carbamoyl]-3-methyl-butyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]carbamoyl]-3-carboxy-propyl]carbamoyl]-2-methyl-butyl]amino]-1-benzyl-2-oxo-ethyl]amino]-1-(carboxymethyl)-2-oxo-ethyl]carbamoyl]-4-oxo-butyl]amino]-1-methyl-2-oxo-ethyl]carbamoyl]-4-guanidino-butyl]carbamoyl]-4-guanidino-butyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(carboxymethyl)-2-oxo-ethyl]amino]-5-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-5-amino-2-[[(2R)-2-[[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]amino]-3-hydroxy-propanoyl]amino]-5-oxo-pentanoyl]amino]acetyl]amino]-3-hydroxy-butanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxy-butanoyl]amino]-4-oxo-butanoyl]amino]-3-carboxy-propanoyl]amino]-3-methyl-butanoyl]amino]-3-hydroxy-propanoyl]amino]hexanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-6-oxo-hexyl]amino]-2-(hexadecanoylamino)-5-oxo-pentanoic acid

ID: ALA5218881

Chembl Id: CHEMBL5218881

PubChem CID: 168298565

Max Phase: Preclinical

Molecular Formula: C207H319N57O65

Molecular Weight: 4646.16

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)CC)C(=O)O

Standard InChI:  InChI=1S/C207H319N57O65/c1-12-14-15-16-17-18-19-20-21-22-23-24-28-56-157(280)232-131(205(328)329)67-71-156(279)221-75-36-33-49-125(236-184(307)133(84-114-57-61-118(273)62-58-114)242-178(301)124(48-32-35-74-209)237-194(317)147(104-270)256-198(321)166(107(5)6)258-191(314)141(92-165(291)292)248-186(309)138(89-155(214)278)250-201(324)169(112(11)272)260-190(313)135(85-115-59-63-119(274)64-60-115)249-200(323)168(111(10)271)257-160(283)97-227-173(296)128(65-69-152(211)275)239-192(315)144(101-267)252-172(295)121(210)87-117-94-220-105-229-117)180(303)246-140(91-164(289)290)188(311)254-145(102-268)193(316)238-127(51-38-77-223-207(218)219)177(300)234-126(50-37-76-222-206(216)217)176(299)231-109(8)171(294)233-129(66-70-153(212)276)181(304)247-139(90-163(287)288)187(310)243-134(83-113-43-26-25-27-44-113)189(312)259-167(108(7)13-2)199(322)240-130(68-72-162(285)286)182(305)244-136(86-116-93-224-122-46-30-29-45-120(116)122)185(308)241-132(82-106(3)4)183(306)235-123(47-31-34-73-208)179(302)245-137(88-154(213)277)174(297)226-95-158(281)225-98-161(284)261-78-39-52-148(261)196(319)255-146(103-269)195(318)253-143(100-266)175(298)228-96-159(282)230-110(9)202(325)263-80-41-54-150(263)204(327)264-81-42-55-151(264)203(326)262-79-40-53-149(262)197(320)251-142(99-265)170(215)293/h25-27,29-30,43-46,57-64,93-94,105-112,121,123-151,166-169,224,265-274H,12-24,28,31-42,47-56,65-92,95-104,208-210H2,1-11H3,(H2,211,275)(H2,212,276)(H2,213,277)(H2,214,278)(H2,215,293)(H,220,229)(H,221,279)(H,225,281)(H,226,297)(H,227,296)(H,228,298)(H,230,282)(H,231,299)(H,232,280)(H,233,294)(H,234,300)(H,235,306)(H,236,307)(H,237,317)(H,238,316)(H,239,315)(H,240,322)(H,241,308)(H,242,301)(H,243,310)(H,244,305)(H,245,302)(H,246,303)(H,247,304)(H,248,309)(H,249,323)(H,250,324)(H,251,320)(H,252,295)(H,253,318)(H,254,311)(H,255,319)(H,256,321)(H,257,283)(H,258,314)(H,259,312)(H,260,313)(H,285,286)(H,287,288)(H,289,290)(H,291,292)(H,328,329)(H4,216,217,222)(H4,218,219,223)/t108-,109-,110-,111+,112+,121-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144+,145-,146-,147-,148-,149-,150-,151-,166-,167-,168-,169-/m0/s1

Standard InChI Key:  UWEJYARXEQDRHW-BHABUTBNSA-N

Alternative Forms

  1. Parent:

    ALA5218881

    ---

Associated Targets(Human)

GLP1R Tclin Glucagon-like peptide 1 receptor (111429 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GCGR Tclin Glucagon receptor (2563 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 4646.16Molecular Weight (Monoisotopic): 4643.3409AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Jiang N, Jing L, Li Q, Su S, Yang Q, Zhou F, Chen X, Han J, Tang C, Tang W..  (2021)  Design of novel Xenopus GLP-1-based dual glucagon-like peptide 1 (GLP-1)/glucagon receptor agonists.,  212  [PMID:33422984] [10.1016/j.ejmech.2020.113118]

Source